Novo Nordisk files lawsuit against Mylan for generic application
The two pharmaceutical companies are facing a legal battle after Mylan filed a new drug application for a generic of Novo Nordisk’s Victoza.
List view / Grid view
The two pharmaceutical companies are facing a legal battle after Mylan filed a new drug application for a generic of Novo Nordisk’s Victoza.
The EMA has given its approval recommendation to three drugs and announced negative opinions for approval on others.
The FDA has approved an injection for use in patients aged 10-17 to treat type 2 diabetes.